G
GLP1 Lawsuit
Mass Tort Case Review
Call
GLP-1 Drug Injury

Ozempic Thyroid Cancer Lawsuit

GLP-1 drugs carry a boxed warning for thyroid C-cell tumors based on rodent studies. Lawsuits are now examining whether real-world thyroid cancer diagnoses — including medullary thyroid cancer — are linked to semaglutide and tirzepatide use.

Call (717) 724-7503

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.

The boxed warning

Ozempic, Wegovy, Mounjaro, and Zepbound all carry a black-box warning regarding thyroid C-cell tumors and contraindicate use in patients with a personal or family history of medullary thyroid cancer (MTC) or MEN-2 syndrome.

When you may have a claim

You may qualify if you were diagnosed with thyroid cancer (especially medullary) during or after GLP-1 use, with no prior personal or family history that contraindicated the drug.

Frequently Asked Questions

Get your free, confidential case review

Takes under 60 seconds. No fee unless you win.

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.